PRESS RELEASE: Tactical Therapeutics, Inc. and Investigators to Present CTO Results at the Annual American Society of Clinical Oncology Meeting

NEW YORK–(BUSINESS WIRE)–Tactical Therapeutics, Inc., a clinical stage oncology drug development company, announced today it is scheduled to present study results of its lead drug Carboxyamidotriazole Orotate (CTO) at the annual American Society of Clinical Oncology meeting taking place May 29th to June 2nd in Chicago, Illinois. The poster will be presented by the investigators on Monday […]

View post →

PRESS RELEASE: Tactical Therapeutics, Inc., Selected to Present at Cavendish Global Health Impact Forum

New York, April 2, 2015, — Tactical Therapeutics, Inc., a clinical stage oncology drug development company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 10th to May 14th in La Jolla, California. The purpose of the Forum is to help family offices and foundations develop and implement their […]

View post →